Limbic circuits and monoamine receptors: Dissecting the effects of antipsychotics from disease processes

Journal of Psychiatric Research

Volumn 31, Issue 2, 1997, Pages 197-217

  Joyce, Jeffrey N ^a   Goldsmith, S G ^a,b   Gurevich, Eugenia V ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 3 RECEPTOR; NEUROLEPTIC AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR;

ANHEDONIA; DEPRESSION; DOPAMINERGIC SYSTEM; HUMAN; LIMBIC SYSTEM; PATHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; TEMPORAL LOBE;

EID: 0030742253     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(96)00043-X     Document Type: Article

References (69)

1. Akbarian, S., Vinuela, A., Kim, J. J., Potkin, S. G., Bunney, W. E. Jr, & Jones, E. G. (1993). Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Archives of General Psychiatry, 50, 178-187.
2. Akil, M., & Lewis, D. E. (1994). The distribution of tyrosine hydroxylase-immunoreactive fibers in the human entorhinal cortex. Neuroscience, 60, 857-874.
3. Alexander, G. E., & Crutcher, M. D. (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends in Neuroscience, 13, 266-271.
4. Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Reviews in Neuroscience, 9, 357-381.
5. Amalric, M., & Koob, G. F. (1993). Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system. Progress in Brain Research, 99, 209-226.
6. Amaral, D. G. (1993). Emerging principles of intrinsic hippocampal organization. Current Opinions in Neurobiology, 3, 225-229.
7. Arnold, S. E., Franz, B. R., & Trojanowski, J. Q. (1994). Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiology of Aging, 15, 299-303.
8. Arnold, S. E., Gur, R. E., Shapiro, R. M.; Fisher, K. R., Moberg, P. J., Gibney, M. R., Gur, R. C., Blackwell, P., & Trojanowski, J. Q. (1995). Prospective clinicopathological studies of schizophrenia: accrual and assessment. American Journal of Psychiatry, 152, 731-737.
9. Arnold, S. E., Hyman, B. T., Van Hoesen, G. W., & Damasio, A. R. (1991). Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry, 48, 625-632.
10. Arnold, S. E., Lee, V. M., Gur, R. E., & Trojanowski, J. Q. (1991) Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proceedings of the National Academy of Sciences U.S.A., & 88, 10850-10854.
11. 2) receptor binding in the frontal cortex of schizophrenic patients. Journal of Neural Transmission [GenSect], 85, 19-29.
12. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology, 14, 35-46.
13. Berger, B., Gaspar, P., & Verney, C. (1991). Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends in Neuroscience, 14, 21-27.
14. Bouthenet, M.-L., Souil, E., Martres, M.-P., Sokoloff, P., Giros, B., & Schwartz, J.-C. (1991). Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization hystochemistry: comparison with dopamine D2 receptor mRNA. Brain Research, 564, 203-219.
15. 2A receptor mRNA in human brain. Brain Research, 676, 157-168.
16. Coirini, H., Schumacher, M., Angulo, J. A., & McEwen, B. S. (1990). Increase in striatal dopamine D2 receptor mRNA after lesions or haloperidol treatment. European Journal of Pharmacology, 186, 369-371.
17. Csernansky, J. G., Murphy, G. M., & Faustman, W. O. (1991). Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biological Psychiatry, 30, 383-400.
18. Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991). Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry, 148, 1474-1486.
19. Diaz, J., Lévesque, D., Lammers, C. H., Griffon, N., Martres, M.-P., Schwartz, J.-C., & Sokoloff, P. (1995). Phenotirical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience, 65, 731-745.
20. Dubovsky, S. L., & Thomas, M. (1995). Serotonergic mechanisms and current and future psychiatric practice. Journal of Clinical Psychiatry, 56(Suppl 2), 38-48.
21. Egan, M. F., Hurd, Y., Hyde, T. M., Weinberger, D. R., Wyatt, R. J., & Kleinman, J. E. (1994). Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigal neurons of rats with neuroleptic-induces dyskenesias. Synapse, 18, 178-189.
22. Fishburn, C. S., David, C., Carmon, S., & Fuchs, S. (1994). The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain. FEBS Letters, 339, 63-66.
23. Goldsmith, S., & Joyce, J. N. (1995). Alterations in the hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biological Psychiatry, 37, 122-126.
24. Goldsmith, S., & Joyce, J. N. (1996). Dopamine D2 receptors are organized in bands in normal human temporal cortex. Neuroscience, in press.
25. Goldsmith, S., & Joyce, J. N. (1994). D2 receptor expression in hippocampus and parahippocampal cortices of human, rat and cat in comparison with tyrosine hydroxylase immunoreactive fibers. Hippocampus, 4, 1-20.
26. Goldsmith, S., Shapiro, R., & Joyce, J. N. (1996). The modular and laminar organization of dopamine D2 receptors in the temporal cortex is disturbed in schizophrenia. Archives of General Psychiatry, in review.
27. Gur, R. E., Jaggi, J. L., Shtasel, D. L., Ragland, J. D., & Gur, R. C. (1994). Cerebral blood flow in schizophrenia: effects of memory processing on regional activation. Biological Psychiatry, 35, 3-15.
28. Gurevich, E. V., Bordelon, Y., Shapiro, R., Arnold, S., Gur, R., & Joyce, J. N. (1997). Elevated mesolimbic dopamine D3 receptors in schizophrenia are decreased by antipsychotics. Archives of General Psychiatry, in press.
29. 2 and D2-dopamine receptor bining in the postmortem human brain. An autoradiographic study. European Neuropsychopharmacology, 5, 19-25.
30. Hogberg, T., Ramsby, S., Ogren, S. O., & Norinder, U. (1987). New selective dopamine D-2 antagonists as antipsychotic agents: pharmacological, chemical, structural and theortical considerations. Acta Pharmacologica Suec, 24, 289-328.
31. Humphrey, T. (1967). The development of the human hippocampal fissure. Journal of Anatomy, 101, 655-676.
32. Joyce, J. N. (1993). The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology, 112, S16-S34.
33. 125I]epidepride binding to dopamine D2 receptors in basal ganglia and cortex of human brain. Journal of Pharmacology & Expimental Therapeutics, 257, 1253-1263.
34. Joyce, J. N., Frohna, P. S., & Neal-Beliveau, B. S. (1996). Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neuroscience and Biobehavioral Reviews, 20, 453-486.
35. Joyce, J. N., Shane, A., Lexow, N., Winokur, A., Casanova, M. F., & Kleinman, J. E. (1993). Serotonin uptake sites and serotonin receptors are altered in limbic system of schizophrenics. Neuropsychopharmacology, 8, 315-336.
36. Joyce, J. N., Sapp, D. W., & Marshall, J. F. (1986). Human striatal dopamine receptors are organized in compartments. Proceedings of the National Academy of Sciences, U.S.A., 83, 8002-8006.
37. Lahti, R. A., Roberts, R. C., & Tamminga, C. A. (1995). D2-family receptor distribution in human postmortem tissue: an autoradiographic study. Neuroreport, 6, 2505-2512.
38. Landwehrmeyer, B., Mengod, G., & Palacios, J. M. (1993). Dopamine D3 receptor mRNA and binding sites in human brain. Molecular Brain Research, 18, 1878-1892.
39. Laruelle, M., Jaskiw, G. E., Kipska, B. K., Kolachana, B., Casanova, M. F., Kleinman, J. E., & Weinberger, D. R. (1992). D1 and D2 receptor modulation in rat striatum and nucleus accumbens after chronic haloperidol treatment. Brain Research, 575, 47-56.
40. Laruelle, M., Abi-Dargham, A., Casanova, M. F., Toti, R., Weinberger, D. R., & Kleinman, J. E. (1993). Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Archives of General Psychiatry, 50, 810-818.
41. Lévesque, D., Martres, M.-P., Diaz, J., Griffon, N., Lammers, C. H., Sokoloff, P., & Schwartz, J.-C. (1995). A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proceedings of National Academy of Sciences, U.S.A., & 92, 1719-1723.
42. Lewis, D. A., Campbell, M. J., Foote, S. L., & Morrison, J. H. (1986). The monoaminergic innervation of the primate neocortex. Human Neurobiology, 5, 181-188.
43. Lidow, M. S., Goldman-Rakic, P. S., & Rakic, P. (1991). Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proceedings of National Academy of Sciences, U.S.A., 88, 10218-10221.
44. 125I]RTI-121 binding sites in human striatum and medial temporal lobe. Journal of Pharmacology & Expimental Therapeutics, 274, 1473-1483.
45. Mackay, A. V. P., Iversen, L., Rossor, M., Spokes, E., Bird, E., Arregui, A., Creese, I., & Snyder, S. H. (1982). Increased brain dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry, 39, 991-997.
46. 2 receptor density in rat cerbral cortex. Life Sciences, 45, 1397-1406.
47. Meador-Woodruff, J. H., Grandy, D. K., Van Tol, H. H. M., Damask, S. P., Little, K. Y., Civelli, O., & Watson, S. J. (1994). Dopamine receptor gene expression in the human medial temporal lobe. Neuropsychopharmacology, 10, 239-248.
48. Meador-Woodruff, J. H., Damask, S. P., Wang, J., Haroutunian, V., Davis, K. L., & Watson, S. J. (1996). Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology, in press.
49. Merchant, K. M., Dobie, D. J., & Dorsa, D. M. (1992). Expression of the proneurotensin gene in the rat brain and its regulation by antipsychotic drugs. Annals of the New York Academy of Sciences, 668, 54-69.
50. Moghaddam, B., & Bunney, B. S. (1990) Acute effect of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem, 54, 1755-1760.
51. Mita, T., Handa, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., & Tanaka, C. (1986). Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biological Psychiatry, 21, 407-1414.
52. Mogenson, G. J., Yang, C. R., & Yim, C. Y. (1988). Influence of dopamine on limbic inputs to the nucleus accubmens. Annals of the New York Academy of Sciences, 537, 86-100.
53. Murray, A. M., Ryoo, H., Gurevich, E., & Joyce, J. N. (1994). Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. Proceedings of the National Academy of Sciences, U.S.A., 91, 11271-11275.
54. O'Dell, S. J., La Hoste, G. J., Widmark, C. V., Shapiro, R. M., Potkin, S. G., & Marshall, J. F. (1990). Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain. Synapse, 6, 146-153.
55. Pearlson, G. D., Petty, R. G., Ross, C. A., & Tien, A. Y. (1996). Schizophrenia: a disease of hetermodal association cortex. Neuropsychopharmacology, 14, 1-18.
56. Rappaport, M. S., Sealfon, S. C., Prikhozhan, A., Huntley, G. W., & Morrison, L. H. (1993). Heterogenous distribution of D1, D2 and D5 receptor mRNAs in monkey striatum. Brain Research, 616, 242-250.
57. Rosene, D. L., & Van Hoesen, G. W. (1987). The hippocampal formation of the primate brain. In E. G. Jones & A. Peters (Eds), Cerebral Cortex Vol 6, (pp. 361-370). New York: Plenum Publishing Corporation.
58. Ryoo, H., & Joyce, J. N. (1994). The loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease. Journal of Comparative Neurology, 348, 94-110.
59. Schoots, O., Seeman, P., Guan, H.-C., Paterson, A. D., & Van Tol, H. H. M. (1995). Long-term haloperidol elvates dopamine D4 receptors by 2-fold in rats. European Journal of Pharmacology, 289, 6772.
60. Seeman, P., Bzowej, N. H., Guan, H. C. Bergeron, C., Reynolds, G. P., Bird, E. D., Riederer, P., Jellinger, K., & Tourtellote, W. W. (1987). Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's and Huntington's disease. Neuropsychopharmacology, 1, 5-15.
61. Seeman, P., Guan. H.-C., & Van Tol, H. H. M. (1993). Dopamine D4 receptors, elevated in schizophrenia. Nature, 365, 441-445.
62. Shapiro, R. M. (1993). Regional neuropathology in schizophrenia: Where are we? Where are we going? Schizophrenia Research, 10, 187-239.
63. Swarzenski, B. C., Tang, L., Oh, Y. J., O'Malley, K. L., & Todd, R. D. (1994). Morphogenic potentials of D2, D3 and D4 dopamine receptors revealed in transfected neuronal cell lines. Proceedings of the National Academy of Sciences, U.S.A., 91, 649-653.
64. Tamminga, C. A., Burrows, G. H., Chase, T. N., Alphs, L. D., & Thaker, G. K. (1988). Dopamine neuronal tracts in schizophrenia; their pharmacology and in vivo glucose metabolism. Annals of the New York Academy of Sciences, 537, 443-450.
65. Tamminga, C. A., Thaker, G. K., Kirkpatrick, B., Alphs, L. D., Chase, N., & Carpenter, W. T. (1992) Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry, 49, 522-530.
66. Todd, R. D. (1992). Neural development is regulated by classical neurotransmitters: dopamine D2 receptor stimulation enhances neurite outgrowth. Biological Psychiatry, 31, 794-807.
67. Weinberger, D. R., Berman, K. F., & Illowsky, B. P. (1988). Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. Archives of General Psychiatry, 45, 609-615.
68. 2) receptors in the rat brain. Brain Research, 487, 288-298.
69. Wolkin, A., Sanfilipo, M., Angrist, B., Duncan, E., Wieland, S., Wolf, A. P., Brodie, J. D., Copper, T. B., Laska, E., & Rostrosen, J. P. (1994). Acute d-amphetamine challenge in schizophrenia: effects on cerebral glucose utilization and clinical symptomatology. Biological Psychiatry, 36, 317-332.